Circulating miR-148b-3p and miR-409-3p as biomarkers for heart failure in patients with mitral regurgitation

Mien Cheng Chen, Tzu Hao Chang, Jen Ping Chang, Hsien Da Huang, Wan Chun Ho, Yu Sheng Lin, Kuo Li Pan, Wen Hao Liu, Yao Kuang Huang

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background MicroRNAs (miRs) regulate gene expression in heart failure. Circulating miRs as biomarkers for heart failure in mitral regurgitation patients (MR) remain unexplored. Methods This case-control study enrolled 32 MR patients with heart failure, 16 asymptomatic MR patients, and 12 control subjects without heart failure. We used next generation sequencing to study the gene expression profiles in the sera, and quantitative RT-PCR to study serum and tissue miRs in the left atria. Results Next generation sequencing analysis and enrichment analysis showed that 25 miRs were differentially expressed in the sera of MR patients with heart failure compared to control subjects. The circulating miR-148b-3p (p = 0.002) and miR-409-3p (p = 0.010) were significantly down-regulated in the MR patients with heart failure compared to control subjects. However, only circulation miR-148b-3p was significantly down-regulated in the MR patients without heart failure compared to control subjects (p = 0.009). The tissue miR-409-3p was significantly down-regulated in the MR patients with heart failure compared to 3 purchased normal controls (p = 0.041). Notably, the tissue RASGRP3 mRNA, target gene of miR-409-3p, was significantly up-regulated in the MR patients with heart failure compared to normal controls (p = 0.010). The tissue FRY (p = 0.010) and GADD45A (p = 0.010) mRNAs, target genes of miR-148b-3p, were significantly up-regulated in the MR patients with heart failure compared to normal controls. Conclusions Circulating miR-148b-3p might serve as biomarker for future development of heart failure and miR-409-3p might serve as biomarker for incident heart failure in MR patients.

Original languageEnglish
Pages (from-to)148-154
Number of pages7
JournalInternational Journal of Cardiology
Volume222
DOIs
Publication statusPublished - Nov 1 2016

Fingerprint

Mitral Valve Insufficiency
Heart Failure
Biomarkers
MicroRNAs
Serum
Messenger RNA

Keywords

  • Atrium
  • Genes
  • Heart failure
  • Mitral regurgitation

ASJC Scopus subject areas

  • Medicine(all)
  • Cardiology and Cardiovascular Medicine

Cite this

Circulating miR-148b-3p and miR-409-3p as biomarkers for heart failure in patients with mitral regurgitation. / Chen, Mien Cheng; Chang, Tzu Hao; Chang, Jen Ping; Huang, Hsien Da; Ho, Wan Chun; Lin, Yu Sheng; Pan, Kuo Li; Liu, Wen Hao; Huang, Yao Kuang.

In: International Journal of Cardiology, Vol. 222, 01.11.2016, p. 148-154.

Research output: Contribution to journalArticle

Chen, Mien Cheng ; Chang, Tzu Hao ; Chang, Jen Ping ; Huang, Hsien Da ; Ho, Wan Chun ; Lin, Yu Sheng ; Pan, Kuo Li ; Liu, Wen Hao ; Huang, Yao Kuang. / Circulating miR-148b-3p and miR-409-3p as biomarkers for heart failure in patients with mitral regurgitation. In: International Journal of Cardiology. 2016 ; Vol. 222. pp. 148-154.
@article{0b98c26df7d34d2eb55b09a12ead2eea,
title = "Circulating miR-148b-3p and miR-409-3p as biomarkers for heart failure in patients with mitral regurgitation",
abstract = "Background MicroRNAs (miRs) regulate gene expression in heart failure. Circulating miRs as biomarkers for heart failure in mitral regurgitation patients (MR) remain unexplored. Methods This case-control study enrolled 32 MR patients with heart failure, 16 asymptomatic MR patients, and 12 control subjects without heart failure. We used next generation sequencing to study the gene expression profiles in the sera, and quantitative RT-PCR to study serum and tissue miRs in the left atria. Results Next generation sequencing analysis and enrichment analysis showed that 25 miRs were differentially expressed in the sera of MR patients with heart failure compared to control subjects. The circulating miR-148b-3p (p = 0.002) and miR-409-3p (p = 0.010) were significantly down-regulated in the MR patients with heart failure compared to control subjects. However, only circulation miR-148b-3p was significantly down-regulated in the MR patients without heart failure compared to control subjects (p = 0.009). The tissue miR-409-3p was significantly down-regulated in the MR patients with heart failure compared to 3 purchased normal controls (p = 0.041). Notably, the tissue RASGRP3 mRNA, target gene of miR-409-3p, was significantly up-regulated in the MR patients with heart failure compared to normal controls (p = 0.010). The tissue FRY (p = 0.010) and GADD45A (p = 0.010) mRNAs, target genes of miR-148b-3p, were significantly up-regulated in the MR patients with heart failure compared to normal controls. Conclusions Circulating miR-148b-3p might serve as biomarker for future development of heart failure and miR-409-3p might serve as biomarker for incident heart failure in MR patients.",
keywords = "Atrium, Genes, Heart failure, Mitral regurgitation",
author = "Chen, {Mien Cheng} and Chang, {Tzu Hao} and Chang, {Jen Ping} and Huang, {Hsien Da} and Ho, {Wan Chun} and Lin, {Yu Sheng} and Pan, {Kuo Li} and Liu, {Wen Hao} and Huang, {Yao Kuang}",
year = "2016",
month = "11",
day = "1",
doi = "10.1016/j.ijcard.2016.07.179",
language = "English",
volume = "222",
pages = "148--154",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Circulating miR-148b-3p and miR-409-3p as biomarkers for heart failure in patients with mitral regurgitation

AU - Chen, Mien Cheng

AU - Chang, Tzu Hao

AU - Chang, Jen Ping

AU - Huang, Hsien Da

AU - Ho, Wan Chun

AU - Lin, Yu Sheng

AU - Pan, Kuo Li

AU - Liu, Wen Hao

AU - Huang, Yao Kuang

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Background MicroRNAs (miRs) regulate gene expression in heart failure. Circulating miRs as biomarkers for heart failure in mitral regurgitation patients (MR) remain unexplored. Methods This case-control study enrolled 32 MR patients with heart failure, 16 asymptomatic MR patients, and 12 control subjects without heart failure. We used next generation sequencing to study the gene expression profiles in the sera, and quantitative RT-PCR to study serum and tissue miRs in the left atria. Results Next generation sequencing analysis and enrichment analysis showed that 25 miRs were differentially expressed in the sera of MR patients with heart failure compared to control subjects. The circulating miR-148b-3p (p = 0.002) and miR-409-3p (p = 0.010) were significantly down-regulated in the MR patients with heart failure compared to control subjects. However, only circulation miR-148b-3p was significantly down-regulated in the MR patients without heart failure compared to control subjects (p = 0.009). The tissue miR-409-3p was significantly down-regulated in the MR patients with heart failure compared to 3 purchased normal controls (p = 0.041). Notably, the tissue RASGRP3 mRNA, target gene of miR-409-3p, was significantly up-regulated in the MR patients with heart failure compared to normal controls (p = 0.010). The tissue FRY (p = 0.010) and GADD45A (p = 0.010) mRNAs, target genes of miR-148b-3p, were significantly up-regulated in the MR patients with heart failure compared to normal controls. Conclusions Circulating miR-148b-3p might serve as biomarker for future development of heart failure and miR-409-3p might serve as biomarker for incident heart failure in MR patients.

AB - Background MicroRNAs (miRs) regulate gene expression in heart failure. Circulating miRs as biomarkers for heart failure in mitral regurgitation patients (MR) remain unexplored. Methods This case-control study enrolled 32 MR patients with heart failure, 16 asymptomatic MR patients, and 12 control subjects without heart failure. We used next generation sequencing to study the gene expression profiles in the sera, and quantitative RT-PCR to study serum and tissue miRs in the left atria. Results Next generation sequencing analysis and enrichment analysis showed that 25 miRs were differentially expressed in the sera of MR patients with heart failure compared to control subjects. The circulating miR-148b-3p (p = 0.002) and miR-409-3p (p = 0.010) were significantly down-regulated in the MR patients with heart failure compared to control subjects. However, only circulation miR-148b-3p was significantly down-regulated in the MR patients without heart failure compared to control subjects (p = 0.009). The tissue miR-409-3p was significantly down-regulated in the MR patients with heart failure compared to 3 purchased normal controls (p = 0.041). Notably, the tissue RASGRP3 mRNA, target gene of miR-409-3p, was significantly up-regulated in the MR patients with heart failure compared to normal controls (p = 0.010). The tissue FRY (p = 0.010) and GADD45A (p = 0.010) mRNAs, target genes of miR-148b-3p, were significantly up-regulated in the MR patients with heart failure compared to normal controls. Conclusions Circulating miR-148b-3p might serve as biomarker for future development of heart failure and miR-409-3p might serve as biomarker for incident heart failure in MR patients.

KW - Atrium

KW - Genes

KW - Heart failure

KW - Mitral regurgitation

UR - http://www.scopus.com/inward/record.url?scp=84982803920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982803920&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2016.07.179

DO - 10.1016/j.ijcard.2016.07.179

M3 - Article

C2 - 27505319

AN - SCOPUS:84982803920

VL - 222

SP - 148

EP - 154

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

ER -